Drug Trial Radar · NCT01965132
Korean College of Rheumatology Biologics and Targeted Therapy Registry
Last checked: Nov 20, 2026Latest source record: Apr 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10,000
Planned (sponsor's estimate)
Start
Dec 1, 2012
Primary completion
Dec 31, 2029
Study completion Jun 30, 2030
Sponsor
- Lead sponsor
- Seoul National University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 18, 2013
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We established a nationwide biologics and targeted synthetic DMARDs registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients receiving biologics or targeted synthetic DMARDs. As this registry is to observe the "real world" use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is planned.
Conditions
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis
Interventions
Biologic or targeted synthetic DMARDDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events during the use of biologics or targeted synthetic DMARDs in Korean patients with Rheumatic diseasesTime frame: up to 10 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seoul Metropolitan Government-Seoul National University Boramae Medical Center
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.